FAST Generics Act of 2019

Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019 This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.